In male rats and mice transgenic for human IAPP, and human islet-engrafted mouse models of T2D, α-IAPP-O triggers clearance of IAPP oligomers resulting in beta cell protection and improved glucose control. Here, IAPP is linked to type 2 diabetes mellitus.